Headway funding, valuation and investors

Overview

Headway builds software that lets therapists accept insurance while helping patients find in-network mental-health care. The company operates one of the largest therapist networks in the U.S. and is expanding into Medicare Advantage and Medicaid.

Why Headway is interesting

Expanding into Medicare Advantage and Medicaid after 34K+ provider milestone; Spark-led D doubled valuation.

Product & use cases

Headway connects patients with in-network therapists and gives providers tools to accept insurance — one of the largest therapist networks in the U.S.

• Patient search for in-network mental-health therapists
• Provider insurance billing and credentialing
• Medicare Advantage and Medicaid expansion

Key facts

• Series D (Feb 2024): $100M led by Spark Capital at $2.3B valuation; Thrive Capital, a16z, and Forerunner Ventures participated — PR Newswire
• Provider network: 34,000+ therapists in-network as of 2024 company disclosures

Funding history (newest first)

Investors in our directory

Funds linked from Headway's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: 34,000+ therapist network with payer integration — solves insurance friction that limits mental-health access.

Mental-health access bottleneck is insurance acceptance. Headway pairs large provider network with payer rails — Spark-led Series D at $2.3B validates scale.

• Lyra Health direct

  Employer-sponsored mental health; Headway insurance-network model.

• Alma direct

  Therapist insurance platform; similar provider tooling.

• BetterHelp adjacent

  Direct-to-consumer teletherapy; cash-pay model.

Notable stories

• 34,000+ therapists in-network as of 2024 company disclosures.
• Series D $100M at $2.3B valuation led by Spark Capital (Feb 2024).

Industries